Suppr超能文献

预测 IgA 肾病患者发生透析或死亡的风险。

Predicting the risk for dialysis or death in IgA nephropathy.

机构信息

Nephrology, Dialysis, and Renal Transplantation Department, University North Hospital, 42055 Saint-Étienne Cedex 2, France.

出版信息

J Am Soc Nephrol. 2011 Apr;22(4):752-61. doi: 10.1681/ASN.2010040355. Epub 2011 Jan 21.

Abstract

For the individual patient with primary IgA nephropathy (IgAN), it remains a challenge to predict long-term outcomes for patients receiving standard treatment. We studied a prospective cohort of 332 patients with biopsy-proven IgAN patients followed over an average of 13 years. We calculated an absolute renal risk (ARR) of dialysis or death by counting the number of risk factors present at diagnosis: hypertension, proteinuria ≥1 g/d, and severe pathologic lesions (global optical score, ≥8). Overall, the ARR score allowed significant risk stratification (P < 0.0001). The cumulative incidence of death or dialysis at 10 and 20 years was 2 and 4%, respectively, for ARR=0; 2 and 9% for ARR=1; 7 and 18% for ARR=2; and 29 and 64% for ARR=3, in adequately treated patients. When achieved, control of hypertension and reduction of proteinuria reduced the risk for death or dialysis. In conclusion, the absolute renal risk score, determined at diagnosis, associates with risk for dialysis or death.

摘要

对于接受标准治疗的原发性 IgA 肾病 (IgAN) 患者个体,预测其长期预后仍然是一个挑战。我们研究了一组前瞻性队列的 332 名活检证实的 IgAN 患者,平均随访 13 年。我们通过计算诊断时存在的风险因素(高血压、蛋白尿≥1g/d 和严重的病理损伤(全球光学评分,≥8))的数量来计算绝对肾脏风险 (ARR)。总体而言,ARR 评分可显著进行风险分层 (P<0.0001)。在充分治疗的患者中,ARR=0 的患者在 10 年和 20 年时的死亡或透析累积发生率分别为 2%和 4%;ARR=1 的患者分别为 2%和 9%;ARR=2 的患者分别为 7%和 18%;ARR=3 的患者分别为 29%和 64%。当实现时,控制高血压和减少蛋白尿可降低死亡或透析的风险。总之,诊断时确定的绝对肾脏风险评分与透析或死亡风险相关。

相似文献

1
Predicting the risk for dialysis or death in IgA nephropathy.预测 IgA 肾病患者发生透析或死亡的风险。
J Am Soc Nephrol. 2011 Apr;22(4):752-61. doi: 10.1681/ASN.2010040355. Epub 2011 Jan 21.
9
Risk stratification of patients with IgA nephropathy.IgA 肾病患者的风险分层。
Am J Kidney Dis. 2012 Jun;59(6):865-73. doi: 10.1053/j.ajkd.2012.02.326. Epub 2012 Apr 11.
10
Long-term survival of patients with IgA nephropathy after dialysis therapy.IgA 肾病患者透析治疗后的长期生存。
Kidney Blood Press Res. 2013;37(6):649-56. doi: 10.1159/000355745. Epub 2013 Dec 14.

引用本文的文献

7
Contemporary Perspectives on Chronic Renal Disorders.慢性肾脏疾病的当代观点
Chronic Dis Transl Med. 2025 Apr 17;11(2):89-104. doi: 10.1002/cdt3.70004. eCollection 2025 Jun.
8
Long non-coding RNA in IgA nephropathy: a comprehensive review.IgA肾病中的长链非编码RNA:综述
Ren Fail. 2025 Dec;47(1):2495836. doi: 10.1080/0886022X.2025.2495836. Epub 2025 May 6.

本文引用的文献

2
Prehypertension: epidemiology, consequences and treatment.高血压前期:流行病学、后果与治疗。
Nat Rev Nephrol. 2010 Jan;6(1):21-30. doi: 10.1038/nrneph.2009.191. Epub 2009 Nov 17.

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验